Compass PathwaysMEX:CMPSN 14 Quick Ratio is 3.32 as of Mar. 2026, which is 77% below its 10-year median of 14.14. GuruFocus rates MEX:CMPSN with a GF Score™ of 14/100. The stock has 2 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Compass Pathways ranks better than 81.7% on this metric.
Compass Pathways has a quick ratio of 3.32. It generally indicates good short-term financial strength.
The historical rank and industry rank for Compass Pathways's Quick Ratio or its related term are showing as below:
MEX:CMPSN'
s Quick Ratio Range Over the Past 10 Years
Min: 0.77 Med: 14.14 Max: 42.82
Current: 3.32
During the past 8 years, Compass Pathways's highest Quick Ratio was 42.82. The lowest was 0.77. And the median was 14.14.
MEX:CMPSN's Quick Ratio is ranked better than 81.7% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 1.32
vs MEX:CMPSN: 3.32
Compass Pathways (MEX:CMPSN) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Compass Pathways Quick Ratio Related Terms
Compass Pathways Quick Ratio Historical Data
* Premium members only.
The historical data trend for Compass Pathways's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:CMPSN vs MD, SGRY, ADUS: Quick Ratio Comparison
For the Medical Care Facilities subindustry, Compass Pathways's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Compass Pathways Quick Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Compass Pathways's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Compass Pathways's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Compass Pathways's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Compass Pathways (MEX:CMPSN) has a Quick Ratio of 3.32 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Compass Pathways and its competitors. This is 77% below median its historical median of 14.14. Over the past decade, Compass Pathways' Quick Ratio has ranged from 0.77 to 42.82. According to the industry distribution chart, Compass Pathways ranks #125 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 18.3%.
Is Compass Pathways' Quick Ratio too high?
Compass Pathways' current Quick Ratio of 3.32 is 77% below median its 10-year median of 14.14. Over the past 10 years, this metric has ranged from a low of 0.77 to a high of 42.82. The Healthcare Providers & Services industry median Quick Ratio is 1.32. Compass Pathways' value of 3.32 is 151.5% above this industry median. Based on the distribution chart, Compass Pathways ranks #125 out of 683 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Compass Pathways has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Compass Pathways' Quick Ratio compare to MD and SGRY?
According to the Healthcare Providers & Services industry distribution chart, Compass Pathways ranks #125 out of 683 companies for Quick Ratio. This places Compass Pathways in the top 18% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.32. Compass Pathways' value of 3.32 is 151.5% above this benchmark. Historically, Compass Pathways' own Quick Ratio has ranged from 0.77 to 42.82 over the past decade. While the company's 10-year median is 14.14 vs. the industry median of 1.32, Compass Pathways has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Healthcare Providers & Services company?
The median Quick Ratio among Healthcare Providers & Services companies is 1.32, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Compass Pathways's current Quick Ratio of 3.32 is 151.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Compass Pathways and its competitors. For the Healthcare Providers & Services industry, the median Quick Ratio is 1.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Compass Pathways's current Quick Ratio is 3.32, which is 77% below median its own 10-year median of 14.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Compass Pathways stock overvalued right now?
Compass Pathways (MEX:CMPSN) has a current Quick Ratio of 3.32. The current Quick Ratio is 3.32, which is 77% below median its 10-year median of 14.14 and 151.5% above the Healthcare Providers & Services industry median of 1.32. Compass Pathways' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Compass Pathways (MEX:CMPSN), the current Quick Ratio is 3.32 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
14GF Score
Get the complete analysis for MEX:CMPSN
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:CMPSN has been successfully added to your 
